Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
G1 Therapeutics

G1 Therapeutics

A company developing small molecule therapies to treat cancer

All edits

Edits on 20 Nov, 2022
Golden AI"update inverses"
Golden AI edited on 20 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Oct, 2022
Golden AI"update inverses"
Golden AI edited on 2 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 19 Sep, 2022
Katrina-Kay Pettitt"prospector:1906:1376672"
Katrina-Kay Pettitt edited on 19 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Edits on 27 Aug, 2022
Wyckliffe Otieno"Goldmine dedupe task response id: 1896628"
Wyckliffe Otieno edited on 27 Aug, 2022
Edits made to:
Infobox (+12 properties)
Article
Article

Infobox
DUNS Number
828732813
Email Address
wroberts@g1therapeutics.com
Fax Number
+19197415830
Industry
Edits on 10 Aug, 2022
Patrick Pum
Patrick Pum edited on 10 Aug, 2022
Edits made to:
Infobox (+6 properties)
Infobox
NAICS code
325,412
CIK number
IRS number
263,648,180
Place of incorporation
Previous name
G-Zero Therapeutics, Inc.
SIC code
2,834
Edits on 28 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 28 Jul, 2022
Edits made to:
Timeline
Timeline

March 29, 2019

On February 5, 2015 G1 Therapeutics completed their series B funding round with $33 million in funding from Ra Capital Management (lead investor), Eshelman Ventures (lead investor), Mountain Group Capital, MedImmune Ventures, Lumira Ventures, and Hatteras Venture Partners.

March 29, 2019

On May 11, 2016 G1 Therapeutics completed their series C funding round with $47 million in funding from Cormorant Asset Management (lead investor), Tavistock Life Sciences, Rock Springs Capital, RA Capital Management, Mountain Group Capital, MedImmune Ventures, Lumira Ventures, Hatteras Venture Partners, Franklin Templeton Investments, Eshelman Ventures, and Cowen Group.

October 16, 2013

On October 16, 2013 G1 Therapeutics completed their series A funding round with $12.5 million in funding from MedImmune Ventures (lead investor), Mountain Group Capital, and Hatteras Venture Partners.

October 12, 2012

On October 12, 2012 G1 Therapeutics completed a venture funding round with $762,900 in funding from undisclosed investors.

Golden AI"remove blacklisted domain URLs"
Golden AI edited on 28 Jul, 2022
Edits made to:
Article
Article

On October 12, 2012 G1 Therapeutics completed a venture funding round with $762,900 in funding from undisclosed investors.

...

On October 16, 2013 G1 Therapeutics completed their series A funding round with $12.5 million in funding from MedImmune Ventures (lead investor), Mountain Group Capital, and Hatteras Venture Partners.

...

On February 5, 2015 G1 Therapeutics completed their series B funding round with $33 million in funding from Ra Capital Management (lead investor), Eshelman Ventures (lead investor), Mountain Group Capital, MedImmune Ventures, Lumira Ventures, and Hatteras Venture Partners.

...

On May 11, 2016 G1 Therapeutics completed their series C funding round with $47 million in funding from Cormorant Asset Management (lead investor), Tavistock Life Sciences, Rock Springs Capital, RA Capital Management, Mountain Group Capital, MedImmune Ventures, Lumira Ventures, Hatteras Venture Partners, Franklin Templeton Investments, Eshelman Ventures, and Cowen Group.

Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Company Operating Status
Active
Founded date
2008
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Edits on 22 Jul, 2022
Golden AI"clean up phone number value"
Golden AI edited on 22 Jul, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Phone number
919-213-9835
Phone number
+19192139835
Edits on 17 Jul, 2022
Golden AI"update inverses"
Golden AI edited on 17 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 11 Jun, 2022
Duzenko Andrey
Duzenko Andrey edited on 11 Jun, 2022
Duzenko Andrey
Duzenko Andrey edited on 11 Jun, 2022
Edits made to:
Infobox (+2 properties)
Infobox
Company Operating Status
Active
Email address
info@g1therapeutics.com
wroberts@g1therapeutics.co
Fax number
919-741-5830
Founded date
2008
Full address
700 Park Offices Drive Suite 200 Research Triangle Park, NC 27709
PO Box 110341 Research Triangle Park, NC 27709
Phone number
919-213-9835
Exchange
Ticker symbol
GTHX
Stock symbol
GTHX
Edits on 1 Jun, 2022
N Ni
N Ni edited on 1 Jun, 2022
Edits made to:
Infobox (+5/-2 properties)
Infobox
Industry
Legal name
G1 Therapeutics, Inc.
Number of Employees (ranges)
100 – 249
Exchange
Ticker symbol
GTHX
Edits on 17 May, 2022
Katrina-Kay Pettitt"prospector:1525:749381"
Katrina-Kay Pettitt edited on 17 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 8 Apr, 2022
Golden AI"Patent autocalculation"
Golden AI edited on 8 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
25
Edits on 1 Mar, 2022
Golden AI"Infobox creation from: 700 Park Offices Drive Suite 200 Research Triangle Park, NC 27709"
Golden AI edited on 1 Mar, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Golden logo
By using this site, you agree to our Terms & Conditions.